Belangrijke positie R&D-locatie Lelystad in onderzoek naar grensoverschrijdende en opkomende dierziekten
Niet alleen de humane gezondheidszorg is in de ban van COVID-19. Ook binnen de veterinaire geneeskunde neemt de vraag naar oplossingen voor zoönosen, grensoverschrijdende en opkomende ziekten toe.
We provide vaccines, diagnostics, research services, technical expertise to ensure safe, affordable, abundant and sustainable quality poultry meat and eggs.
At Boehringer Ingelheim diversity of minds & collaboration is paramount to developing new medical breakthroughs. Click here see how you can partner with us.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
Our livestock business encompasses the poultry, swine, ruminant segments and Veterinary Public Health to address the needs of livestock producers, livestock veterinarians, government officials and NGOs.
Click to discover the importance of clinical studies for developing new medicines & see some of the clinical trials Boehringer Ingelheim have sponsored.